Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Ananth Kumar thinks for separate Ministry of Pharmaceuticals
Shri Ananth Kumar said that he is also pushing for the idea for a separate Ministry of Pharmaceutical and Medical Devices, so as to give a boost to the sector at the Annual Conference of Pharmaceuticals and Medical Devices in New Delhi. It plays important role in promotion, encouragement, enabling atmosphere and regulation in a good measure so that quality affordable drugs are available to the common masses of the country, as per minister.
- Read more about Jan Aushadhi Scheme is being revised to increase the number of medicines
Jan Aushadhi Scheme is being revised to increase the number of medicines and also to allow the shops to sell surgical and consumable items. This was informed in Consultative Committee meeting of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
- Read more about 54th National Pharmacy Week Celebration 2015 at GIP
National Pharmacy Week is being celebrated every year in the last week of November to create awareness among the general public about the role of pharmacist in public health. The Geetanjali Institute of Pharmacy (GIP), Geetanjali University, Manwa Khera, Udaipur actively observed the National Pharmacy Week during 30^th November, to 05^th December, 2015 at the Geetanjali University campus. The theme of 54^th National Pharmacy Week is ‘Responsible Use of Antibiotics Saves Lives’.
- Read more about Report on National Symposium on Exploring New Insights of Pharmacoeconomics and Outcome Research
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) - India, Andhra Pradesh Regional Chapter head office at Raghavendra Institute of Pharmaceutical Education and Research – RIPER, in association with Indian Pharmaceutical Association (IPA) Anantapuramu Branch and Rural Development Trust (RDT) Hospitals Bathalapalli, Anantapuramu, Andhra Pradesh organized an One day “National Symposium on Exploring New Insights of Pharmacoeconomics and Outcome Research” on 5 December 2015 at RDT hospitals.
- Read more about National Pharmacy Week Celebrations 2015 at RIPER
Indian Pharmaceutical Association (IPA) Anantapuramu Local Branch, with branch head office at Raghavendra Institute of Pharmaceutical Education and Research (RIPER), celebrated the National Pharmacy Week – 2015 from 1^st–3^rd December 2015.
- Read more about Key biological markers for psychotic disorders identified
A team of researchers led by the University of Georgia has identified several biological markers that make it possible to classify mental disorders with greater precision. The findings may lead to improved diagnostics and treatments for those suffering from mental illness.

[adsense:336x280:8701650588]
- Read more about Kids with common allergies at high heart disease risk
Children with allergic disease, particularly asthma and hay fever, have twice the rate of high blood pressure and high cholesterol, setting them on course for heart disease at early age, finds a new study.
- Read more about Women loathe preventive drugs for breast cancer
Five in six women with increased risk of breast cancer turn down drugs that are likely to prevent the disease, finds cancer research scientists in Britain.
- Read more about Researchers create World’s first ibuprofen patch
Researchers at the University of Warwick have worked with Coventry-based Medherant, a Warwick spinout company, to produce and patent the World’s first ever ibuprofen patch delivering the drug directly through skin to exactly where it is needed at a consistent dose rate.
- Read more about USFDA Approve QuilliChew ER chewable tablets
Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved QuilliChew ER chewable tablets. Pfizer now offers two different products for the treatment of ADHD in patients ages 6 years old and above – liquid Quillivant XR® (methylphenidate HCl) CII and new QuilliChew ER chewable tablets.